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Abstract The study objective was to explore the diagnostic
suitability of the Xerostomia Inventory and the association
between xerostomia, hyposalivation and medication use in
a group of nursing home residents. A cross-sectional study
was carried out in 50 physically impaired nursing home
residents (20 men) with a mean age of 78.1 years (range,
53–98) in The Netherlands. The Xerostomia Inventory-
Dutch version was completed for all residents and the data
were subjected to exploratory factor analysis to determine
the diagnostic suitability. Residents’ data on xerostomia,
whole saliva secretion rates and hyposalivation-related
medications used were collected and statistically analyzed.
The diagnostic suitability of the Xerostomia Inventory-
Dutch version appeared restricted. The prevalence of
xerostomia was 52%, without gender and age difference.
The prevalence of hyposalivation was 24% for resting, 60%
for chewing-stimulated and 18% for acid-stimulated whole
saliva. All whole saliva secretion rates were significantly
lower in women than in men and in older than in younger
residents. Forty-four percent of all medications used were
hyposalivation-related and women used significantly more
medications than men. Xerostomia was significantly nega-
tively correlated with the resting whole saliva secretion rate.
The number of hyposalivation-related medications used
was not significantly correlated with the various whole
saliva secretion rates. In nursing home residents, xerosto-
mia, hyposalivation and using hyposalivation-related med-
ications seem common and partially associated features.
Keywords Xerostomia.Hyposalivation.Medication.
Nursinghome.XerostomiaInventory
Introduction
Presumably, more than 30% of the population of 65 years
of age and older are experiencing xerostomia, subjective
oral dryness [1, 2]. Due to lack of studies in general
population-based samples, a literature review on the
prevalence of xerostomia was not conclusive: 13–26% for
men and 20–46% for women [3]. Data on xerostomia
prevalence in frail and institutionalized elderly patients are
scarce as well. The few studies established, reported higher
figures when compared with the before-mentioned literature
review [3]. In a cohort of 99 institutionalized elderly
patients with a mean age of 82.5 years, 51% had noticed
subjective symptoms of xerostomia [4]. In groups of frail
elderly home-living and hospitalized patients, the preva-
lence of xerostomia was 57% and 63%, respectively [5].
A significant number of patients with complaints of
xerostomia are not showing objectively assessed salivary
hypofunction (hyposalivation) [1, 6]. It has been suggested
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DOI 10.1007/s00784-010-0382-1that the visco-elastotic properties of their whole saliva may
have altered, for instance by diminished minor salivary
gland secretion, failing to lubricate the mouth properly [6,
7]. Another theory suggested is that the patient’s perception
mechanisms may have altered [6].
To maintain good oral and general health, an adequate
amount of saliva should be secreted [6, 8]. Hyposalivation
may contribute to several oral complaints, such as xero-
stomia, generalized oral discomfort, burning mouth and
tongue, traumatic oral lesions, halitosis, intolerance to
acidic and spicy foods, poor retention of dentures,
disturbances in taste and mastication, polydipsia, dysgeusia,
dysphasia and dysphonia [9–12]. Hyposalivation may
induce tooth wear, oral soft tissue lesions and micro-
organism colonisation, inducing caries, candidiasis and less
frequently periodontal disease [8, 11–14]. Oral complaints
and symptoms due to hyposalivation are contributing to
reduced quality of life [15, 16].
A review study on salivary gland function and ageing
reported age-related resting whole saliva secretion decrease,
but mixed results of stimulated whole saliva secretion rates
[1]. The results of two subsequent studies suggested an
age-related reduction of stimulated whole saliva secretion
in women [17, 18]. In several studies, older people showed
statistically significant reduced resting whole saliva secre-
tion rates, when compared with younger people [19–21].
Histomorphometric examination of salivary gland tissue
demonstrated a decrease in the acinar volume, an increase
in the ductal volume and replacement of acinar cells with
adipose and fibrotic tissues during ageing [1, 22]. In labial
salivary glands, the mean volume fraction of seromucous
and mucous acinar cells showed statistically significant
lower values in elderly people when compared with
younger people. The mean seromucous and mucous volume
fractions were decreased in the elderly by 49% and 28%,
respectively [23]. It was hypothesized that, nevertheless,
most of the salivary gland functions in the elderly are
carried out uncomplicated due to the fact that the remaining
acinar cells are structurally intact, retain their functional
efficiency and are sufficient in quantity. In other words: a
secretory reserve may exist to preserve adequate salivary
gland function despite the loss of acinar cells [1, 20, 24].
Statistically significant age-related decreases of major and
minor salivary glands secretion rates were obvious in
several studies [1, 25, 26]. However, some prospective
and longitudinal studies showed that the function of major
and minor salivary glands was not age-related [1, 18, 27].
Nagler and Hershkovich (2005) suggested that the
reduced resting whole saliva secretion rates in a study
group of elderly people were due to the fact that some
people received medications for age-related diseases [20].
In a group of elderly people, anticholinergic medication use
was common and the prevalence of xerostomia was
statistically significant higher in those using anticholinergic
medications [28]. In another study, users of medications
displayed statistically significant reduced resting and
stimulated saliva secretion rates of the major salivary
glands when compared to non-users [29]. As reported by
several investigators previously, hyposalivation seems
mainly a consequence of medication use, systemic diseases,
head and neck radiotherapy, Sjögren syndrome and/or
dehydration [1, 2, 6, 30, 31].
Because of the subjective scope, xerostomia can only be
assessed by questioning, using discriminative questions.
During the last decades, several questionnaires have been
developed [30]. A frequently used questionnaire in research
projects on xerostomia is the Xerostomia Inventory [32].
Eleven items of the Xerostomia Inventory are covering both
experiential and behavioural aspects of xerostomia (Table 1).
Scores to the 11 items are summated, providing a single
score representing the subjective severity of xerostomia. The
questionnaire has shown acceptable content and concurrent
validity, responsiveness, temporal stability and longitudinal
construct validity [32–34]. The Xerostomia Inventory has
Item number Proposition R
1 I sip liquids to aid in swallowing food 0.55
2 My mouth feels dry when eating a meal 0.63
3 I get up at night to drink –
4 My mouth feels dry 0.62
5 I have difficulty in eating dry foods 0.63
6 I suck sweets or cough lollies to relieve dry mouth 0.37
7 I have difficulties swallowing certain foods 0.61
8 The skin of my face feels dry 0.58
9 My eyes feel dry 0.49
10 My lips feel dry 0.68
11 The inside of my nose feels dry –
Table 1 Items of the Xerosto-
mia Inventory-Dutch version
and their Pearson’s correlation
coefficients (R) with the latent
variable ‘xerostomia’
186 Clin Oral Invest (2011) 15:185–192already been used for examining the association between
medication exposure and severity of xerostomia in older
people [34, 35].
Although xerostomia is not related to hyposalivation
obviously, it is a symptom which deserves attention of oral
health care and other health care professionals because of
its feasible great impact on oral health, general health and
quality of life. Certain items or a certain summated score of
the Xerostomia Inventory may be indicative of hyposaliva-
tion, directing towards objective assessment and eventually
management of hyposalivation.
The aim of this study was exploring the diagnostic
suitability of the Xerostomia Inventory and the association
between xerostomia, hyposalivation, and medication use in
nursing home residents. Four objectives were formulated.
The first objective was to examine the diagnostic suitability
of a Dutch translation of the Xerostomia Inventory for
determining the severity of xerostomia. A second objective
was to assess the prevalence of xerostomia, the prevalence
of hyposalivation, the number of hyposalivation-related
medications used, and gender and age differences of these
three variables. The third objective was to determine the
correlation of xerostomia with whole saliva secretion rates.
The fourth objective was to determine the correlation of the
number of hyposalivation-related medications used with
whole saliva secretion rates.
Material and methods
A cross-sectional study was carried out in a group of
physically impaired nursing home residents. The study
design was reviewed and approved by the Medical Ethic
Committee of the Netherlands. All subjects gave informed
written consent about their participation in the study.
Study group
The original study group consisted of 55 physically
impaired residents of a nursing home in The Netherlands.
The nursing home was not diverging from all nursing
homes in The Netherlands with respect to age, gender,
medical diagnoses, comorbidity, dependency and length of
stay of the residents. Three residents decided not to
participate and two suffered from apraxia and were
excluded consequently. Additional exclusion criteria were:
terminally ill, cognitive impairment, fever, dehydration,
Sjögren’s syndrome, and previously received radiotherapy
in the head and neck region. None of the 50 residents (20
men) remaining from the original study group, did meet one
or more of the additional exclusion criteria. Their mean age
was 78.1 years (range, 53–98). The mean age of the men
was 76.8 years and of the women 79.0 years, a not
statistically significant difference. Nine participating resi-
dents were younger than 70 years of age, 25 were in the age
group 70–80, and 16 were older than 80 years of age.
Xerostomia
The original English version of the Xerostomia Inventory
was translated into Dutch following the repeated back-
translation procedure. The response options to the 11
propositions of the Xerostomia Inventory are ‘never’,
‘hardly ever’, ‘occasionally’, ‘fairly often’ or ‘very often’.
Preceding the main study, a pilot study was carried out in
15 physically impaired nursing home residents to examine
the ability of the residents to discriminate between the five
response options. The pilot study revealed that the residents
were experiencing several discriminating problems. Conse-
quently, it was decided to reduce the number of response
options from 5 to 3: ‘never’ (score 1), ‘occasionally’ (score
2) and ‘ever’ (score 3). The thus modified Xerostomia
Inventory is called Xerostomia Inventory-Dutch version
and the summated score of this version is called Summated
Xerostomia Inventory-Dutch version. The Summated Xero-
stomia Inventory-Dutch version represents a resident’s
experienced severity of xerostomia, providing a score
between 11 and 33.
For all participating residents a Xerostomia Inventory-
Dutch version questionnaire was completed and the
Summated Xerostomia Inventory-Dutch version was
assessed.
Whole saliva secretion rates
Saliva was collected from all participating residents. The
collecting time was between 9:30 AM and 12:30 PM to avoid
circadian effects [36]. The residents were instructed to
refrain from eating, smoking and drinking coffee and tea
during 1.5 h prior to the saliva collection. Drinking tap
water was permitted. During the saliva collection, the
residents were requested to seat straight and to refrain from
speaking and swallowing. Resting and stimulated whole
saliva’s were collected according to the spitting method by
spitting all oral fluid currently available in the mouth, into a
pre-weighed test tube [37]. First, resting whole saliva was
collected during 5 min. Every 30 s the residents spitted the
oral fluid available in the mouth. After a 2-min break,
chewing-stimulated whole saliva was collected during
5 min using a tasteless piece of Parafilm (5×5 cm; 0.3 g).
Every 30 s the residents spitted the oral fluid available in
the mouth. Finally, after another 2-min break, acid-
stimulated whole saliva was obtained by sweeping the
tongue margins and tongue tip with a cotton swab soaked in
a 4% citric acid solution every 20 s. During 2 min the
residents spitted every 20 s the oral fluid available in the
Clin Oral Invest (2011) 15:185–192 187mouth. All oral fluid volumes were determined gravimet-
rically, assuming 1 g as equivalent to 1 ml whole saliva.
The hyposalivation cut-off values used were 0.1 ml/min
for resting whole saliva and 0.5 ml/min for chewing-
stimulated as well as acid-stimulated whole saliva [1].
Hyposalivation-related medications used
Groups of medications most commonly indicated as cause
of hyposalivation have been listed by Scully (2003) [31].
From the residents’ medical records, all and hyposalivation-
related [31] medications were registered.
Statistical analysis
The Xerostomia Inventory-Dutch version data were sub-
jected to exploratory factor analysis to reveal the range of
the 11 proposition responses, possibly providing one latent
variable determining the severity of xerostomia.
For determining the correlation of xerostomia and the
number of hyposalivation-related medications used with
whole saliva secretion rates, the residents’ whole saliva
secretion rates were dichotomized: below and equal or
above the hyposalivation cut-off values.
To assess possible correlations of (1) xerostomia, whole
saliva secretion rates as well as the number of hyposalivation-
related medications used with gender and age, (2)
xerostomia with whole saliva secretion rates, and (3)
the number of hyposalivation-related medications used
with whole saliva secretion rates, additional statistical
analysis was performed by analysis of variance ((M)
ANOVA) using SPSS-pc version 14.0 (SPSS Inc. Chicago,
IL, USA). A P value of 0.05 was considered to be
statistically significant.
Results
Xerostomia Inventory-Dutch version
Exploratory factor analysis of the Xerostomia Inventory-
Dutch version data resulted in four eigenvalues higher than
1 and one eigenvalue higher than 3, respectively, 1.09,
1.23, 1.29 and 3.71. The eigenvalue of 3.71 represented a
factor providing a single latent variable for xerostomia. The
factor load showing the Pearson’s correlation coefficients of
all Xerostomia Inventory-Dutch version items with the
latent variable ‘xerostomia’ is shown in Table 1. Xerosto-
mia Inventory-Dutch version items 3 and 11 did not show
any correlation with the latent variable ‘xerostomia’. Items
2, 4, 5, 7 and 10 demonstrated Pearson’s correlation
coefficients above 0.6. Varimax rotation and 0.35 as
maximal convergence for iteration were used. The stronger
the correlation of an item with the factor ‘xerostomia’, the
more frequent ‘ever’ (score 3) was responded to that
particular item. The weaker the correlation of an item with
the factor ‘xerostomia’, the more frequent ‘never’ (score 1)
was responded to that particular item.
Xerostomia
The Xerostomia Inventory-Dutch version item scores and
mean item scores are presented in Table 2. The mean
Summated Xerostomia Inventory-Dutch version score was
16.5 (SD=4.2). Based on scores 2 and 3 to Xerostomia
Inventory-Dutch version item 4 (‘My mouth feels dry’), the
prevalence of xerostomia was 52%. Statistically significant
gender differences of xerostomia prevalence were not
observed (men 50%, women 53%; Chi-square test: P=
0.82). Although xerostomia was more prevalent in residents
older than 80 years of age (69%) than in younger residents
(44%), the difference failed to reach significance (Chi-
square test: P=0.10).
Whole saliva secretion rates
The data of resting whole saliva, chewing-stimulated whole
saliva and acid-stimulated whole saliva are presented as
mean values with standard deviations in Tables 3 and 4.
The mean resting whole saliva and acid-stimulated
whole saliva, 0.2 (SD=0.2) and 1.2 (SD=0.9) ml/min,
respectively, were somewhat above the hyposalivation cut-
off values. The mean chewing-stimulated whole saliva of
0.5 (SD=0.5) ml/min was equal to the hyposalivation cut-
off value(Table3). In 48% of the residents, the resting whole
saliva was less than 0.2 and in 24% less than 0.1 ml/min.
The chewing- and acid-stimulated whole saliva were less
Table 2 Xerostomia Inventory-Dutch version item scores and mean
item scores (n=50)
Item number Never Occasionally Ever Mean score
Score 1 Score 2 Score 3
1 24 12 14 1.8
2 35 8 7 1.4
3 32 7 11 1.6
4 24 13 13 1.8
5 34 7 9 1.5
6 37 11 2 1.3
7 37 9 4 1.3
8 34 11 5 1.4
9 39 7 4 1.3
10 21 20 9 1.8
11 40 8 2 1.2
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respectively.
The mean values of resting whole saliva, chewing- and
acid-stimulated whole saliva were lower in women, when
compared to men (Table 3). The mean chewing-stimulated
whole saliva in women of 0.4 (SD=0.5) ml/min was below
the hyposalivation cut-off value. The differences between
men and women were statistically significant, even after
correction for age and the number of hyposalivation-related
medications used (ANOVA; USW: P<0.01; chewing- and
acid-stimulated whole saliva: P<0.05).
Age was statistically significant negatively correlated
with resting whole saliva, chewing- and acid-stimulated
whole saliva after correction for gender and number of
hyposalivation-related medications used (ANOVA; USW:
P<0.05; chewing- and acid-stimulated whole saliva: P=
0.05). The mean chewing-stimulated whole saliva of the
people older than 80 years of age of 0.4 (SD=0.3) ml/min
was, although not statistically significant, lower than the
hyposalivation cut-off value (Table 3).
Hyposalivation-related medications used
The total number of all types of medications used at the
time of the investigation was 207 and the number of
hyposalivation-related medications used was 91 (Table 5).
This means that 44% of all medications used were
hyposalivation-related.
All except one resident used one or more medications.
The mean number of all types of medications used by the
49 residents was 4.2 (SD=2.6). Twenty-seven residents
used hyposalivation-related medications, with a mean
number of 3.4 (SD=2.2). The numbers of both all types
of medications and hyposalivation-related medications used
by the 49 and 27 residents respectively were statistically
significant higher in women when compared with men
(Chi-square test: P<0.01 and P<0.05, respectively). An age
difference could not be detected.
Correlation of xerostomia with whole saliva secretion rates
The scores to the Xerostomia Inventory-Dutch version
items 2 and 4 in relation to mean scores and standard
deviation of resting whole saliva, chewing- and acid-
stimulated whole saliva are shown in Table 4. ANOVA
revealed that scores 2 and 3 to Xerostomia Inventory-Dutch
version items 2 and 4 were statistically significant nega-
tively correlated with resting whole saliva (item 2: P<0.01;
item 4: P<0.05). Scores 3 to items 2 and 4 were correlated
with resting whole saliva below the hyposalivation cut-off
value, respectively in all cases for item 2 and in 78% of
cases for item 4. Of those residents who scored 1 to
Xerostomia Inventory-Dutch version item 4, 33% had
resting whole saliva below the hyposalivation cut-off value.
Statistically significant gender and age differences could
not be demonstrated.
Correlation of number of hyposalivation-related
medications used with whole saliva secretion rates
No statistically significant correlation could be assessed
between on the one hand the number of hyposalivation-
related medications used and on the other hand resting
whole saliva, chewing- and acid-stimulated whole saliva
(ANOVA: P=0.23, P=0.13 and P=0.09 respectively).
Discussion
Exploratory factor analysis of the Xerostomia Inventory-
Dutch version data showed one latent variable for xero-
Table 4 Scores of the 50 residents to items 2 and 4 of the Xerostomia
Inventory-Dutch version (XI-D) in relation to mean scores (ml/min)
and standard deviations (±) of resting (RWS), chewing-stimulated
(CH-SWS) and acid-stimulated (A-SWS) whole saliva secretion rates
XI-D-item Score n Secretion rates
RWS CH-SWS A-SWS
2 1 35 0.3±0.2 0.5±0.5 1.2±1.0
2 2 8 0.3±0.2 0.7±0.7 1.2±0.6
2 3 7 0.1±0.1 0.5±0.3 1.1±0.6
4 1 24 0.3±0.2 0.5±0.5 1.3±1.1
4 2 13 0.2±0.2 0.5±0.3 1.0±0.4
4 3 13 0.2±0.2 0.7±0.6 1.4±0.7
Table 3 Mean secretion rates (ml/min) and standard deviations (±) of resting whole saliva (RWS), chewing-stimulated whole saliva (CH-SWS)
and acid-stimulated whole saliva (A-SWS), separately for men and women and for age group (<70; 70–80; >80)
Whole saliva type
(cut-off value for hyposalivation)
men women all <70 70-80 >80
n=20 n=30 n=50 n=8 n=25 n=16
RWS (0.1) 0.4±0.2 0.1±0.1 0.2±0.2 0.3±0.2 0.2±0.2 0.2±0.2
CH-SWS (0.5) 0.8±0.6 0.4±0.5 0.5±0.5 0.6±0.7 0.5±0.5 0.4±0.3
A-SWS (0.5) 1.6±1.0 0.9±0.6 1.2±0.9 1.3±0.8 1.2±1.0 1.1±0.6
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correlation coefficients with the items 2, 4, 5, 7 and 10.
Based on these results, the diagnostic suitability of the
Xerostomia Inventory-Dutch version seems restricted. A
modified Xerostomia Inventory-Dutch version containing
only items 2, 4, 5, 7 and 10 might be a suitable inventory of
the severity of xerostomia symptoms, which deserves
further scientific exploration.
The variable ‘experiencing dry mouth’ has been used in
several studies to diagnose xerostomia [3]. Item 4 of the
Xerostomia Inventory-Dutch version is representing this
variable. Fifty-two per cent of the residents responded item
3( ‘My mouth feels dry’) by score 2 (occasionally) or 3
(ever). It was assumed that these two scores were
representing the xerostomia prevalence of the present study
group. The figure of 52% is within the range of the figures
of previous studies on prevalence of xerostomia in groups
of institutionalized elderly people (35–63%) and somewhat
higher than in groups of non-institutionalized elderly
people (21–46%) [3–5, 35, 38].
The mean Summated Xerostomia Inventory-Dutch ver-
sion (16.5) is a scarcely relevant outcome because of the
restricted diagnostic suitability of the Xerostomia
Inventory-Dutch version, as concluded in the present study.
Contrary to the results of some previous studies in
mainly elderly people [1, 3, 7, 39, 40], but in accordance
with the result of one previous study in younger adults [41],
xerostomia showed no gender-difference in the present
study. The not conclusive results of previous studies and the
present study are probably due to age-differences, limited
sample sizes, methodological differences and diagnostic
criteria used.
Women had a statistically significant lower mean resting
whole saliva secretion rate when compared to men. This
phenomenon has also been reported in several previous
studies [1, 11, 31, 42]. It has been suggested that the
menopause and female hormone oestrogen are influencing
the salivary function in common with many other physio-
logical and psychological functions. However, the results of
reports on the correlation of menopause, oestrogen, and
menopausal hormonal replacement therapy with the various
saliva secretion rates are not conclusive [18, 25, 43].
Age-related resting whole saliva secretion decrease
occurs unarguably, especially in elderly people [1]. How-
ever, it is not yet revealed which percentage of (institution-
alized) elderly people are suffering from resting whole
saliva secretion rates below the hyposalivation cut-off
value. In the present study group of physically impaired
nursing home residents, this figure was 24%. Similar results
were reported in two studies in non-institutionalized elderly
people (20–29%) [21, 32].
It is hardly possible to compare the data of hyposalivation-
related medications used in the present study group with
similar groups of patients because of scarceness of
literature reports. In a more than 20 years old study,
761 institutionalized elderly people were taking on
average four medications (present study group 4.2; SD=
2.6) and 47% of them were taking one or more
hyposalivation-related medications [44]. Thomson et al.
(2000) found a mean number of 3.2 (SD=2.6) medications
used in a group of non-institutionalized elderly people, but
no distinction was made between types of medications,
gender and age [34]. The results of the present study are
confirming that many nursing home residents are using
(several) hyposalivation-related medications. Probably,
these medication use figures would have been higher when
also cognitively impaired elderly people had been included
in the present study.
Thirty-three per cent of the study group had score 1
(never) to the Xerostomia Inventory-Dutch version item 4
(‘My mouth feels dry’), whereas their resting whole saliva
was below the cut-off value. Explanations proposed for this
disparity are that alterations have occurred in patient’s
perception mechanisms and that the questions diagnosing
xerostomia are not satisfactory [1, 6, 7]. Due to the specific
character of the present study group, additional explan-
ations may be: overshadowing of the problem by more
intensive problems, having found ways to compensate
hyposalivation (e.g. drinking while eating), and adaptation
to, acceptance of, and resignation to the feeling of oral
dryness.
Items 2 and 4 of the Xerostomia Inventory-Dutch
version showed a statistically significant correlation with
hyposalivation, defined as resting whole saliva secretion
rate below 0.1 ml/min. Positive responses to these two
Table 5 Hyposalivation-related medications used by the residents
Medication Number used
Anticholinergic medications
Alpha receptor antagonists for treatment
of urinary retention
5
Antipsychotics, such as phenotiazines 8
Diuretics 9
Antihistamines 4
Sympathomimetic medications
Antihypertensive agents 24
Antidepressants; serotonin agonists
or noradrenaline and/or serotinine
re-uptake inhibitors
7
Bronchodilatators 12
Skeletal muscle relaxants 1
Benzodiazepines, hypnotics, opioids
and medications of abuse
11
H2 antagonists and proton pump inhibitors 9
Cytotoxic medications 1
Total number used 91
190 Clin Oral Invest (2011) 15:185–192items may be a satisfactory and adequate indication for
clinical assessment of hyposalivation by sialometry.
The number of hyposalivation-related medications used
was not statistically significant correlated with the whole
saliva secretion rates. This study result suggests that in
patients using several hyposalivation-related medications,
reducing the number of these medications is not an
adequate recommendation to increase whole saliva secre-
tion rates. Discontinuing the use of hyposalivation-related
medications, if possible and well-considered, may be the
sensible recommendation of choice.
Apart from the common limitations of clinical studies
( i ni m p a i r e de l d e r l yh u m a ns u b j ects), the present study had
some specific limitations. First, the number of subjects
participating was limited. Second, the study group was
very selective and restricted to physically impaired nursing
home residents. In addition, the Xerostomia Inventory-
Dutch version was not used and scientifically examined
previously. Consequently, the results of the study should
be interpreted carefully.
Xerostomia and hyposalivation may alter a patient’s oral
health and quality of life [15, 16]. In order to anticipate this
problem, a good recommendation is drinking regularly and
eating highly fluid-containing food [30]. Hyposalivation
due to medication may be treated by altering the dosage of
the medication or by replacing the medication by an equally
effective, but not or less hyposalivation-inducing medication
[30]. Also gustatory and mechanical salivary stimulating
techniques may be helpful to relieve the feelings of
xerostomia, such as consuming sugar-free chewing gum,
candies, and mints, as well as acidic drinks and foods [30,
45]. Systemic medication of pilocarpine or cevimeline or
application of physostigmine to the oral mucosal surface
may improve saliva secretion, but the possible side effects
should be determined and, if possible, anticipated or
controlled [42, 46, 47]. When stimulating salivary secretion
is not possible or not adequate, symptomatic relief of the oral
complaints becomes the primary management strategy.
Saliva substitutes, lubricating oral gel and intra-oral reser-
v o i r so fs a l i v as u b s t i t u t e sm a yb eu s e d[ 48].
Frequent oral evaluations and oral hygiene instructions
are essential to prevent caries and other oral infections in
hyposalivation-related medications using (institutionalized)
elderly people. Daily topical fluoride use and antimicrobial
mouth rinses may help preventing caries [30, 49].
With regard to the four objectives and within the
limitations of the present study, the results are justifying
some conclusions.
& The diagnostic suitability of the Xerostomia Inventory-
Dutch version seems restricted and a modified version
containing only items 2, 4, 5, 7 and 10 might be a
suitable inventory of the severity of xerostomia.
& The prevalence of xerostomia was 52%, without gender
and age difference.
& The prevalence of hyposalivation was 24% for resting
whole saliva, 60% for chewing-stimulated whole saliva
and18%foracid-stimulatedwholesaliva; allwholesaliva
secretion rates were statistically significant lower in
womenthaninmenandinolderthaninyoungerresidents.
& Forty-four per cent of all medications used were
hyposalivation-related; the mean number of hyposalivation-
related medications used by 27 residents was 3.4
(SD=2.2); the number of hyposalivation-related med-
ications used was statistically significant higher in
women when compared to men.
& Xerostomia was statistically significant negatively
correlated with the resting whole saliva secretion rate.
& The number of hyposalivation-related medications used
was not statistically significant correlated with the
various whole saliva secretion rates.
The results of the present study are one step forward in
exploring the association between xerostomia, hyposaliva-
tion, and medication use, but the issue deserves further
attention scientifically and clinically.
Conclusions
The diagnostic suitability of the Xerostomia Inventory-Dutch
version seems restricted. Xerostomia, hyposalivation and
using hyposalivation-related medications seem common and
partially associated features in nursing home residents.
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